CA2342738A1 - Procede de detection ou de quantification des basophiles et des eosinophiles - Google Patents

Procede de detection ou de quantification des basophiles et des eosinophiles Download PDF

Info

Publication number
CA2342738A1
CA2342738A1 CA002342738A CA2342738A CA2342738A1 CA 2342738 A1 CA2342738 A1 CA 2342738A1 CA 002342738 A CA002342738 A CA 002342738A CA 2342738 A CA2342738 A CA 2342738A CA 2342738 A1 CA2342738 A1 CA 2342738A1
Authority
CA
Canada
Prior art keywords
eosinophils
basophils
antibody
quantification
ril
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002342738A
Other languages
English (en)
French (fr)
Inventor
Felix A. Montero Julian
Anne M. Morel Montero
Herve Brailly
Michel Delaage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunotech SAS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2342738A1 publication Critical patent/CA2342738A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Fire-Detection Mechanisms (AREA)
CA002342738A 1998-09-10 1999-09-09 Procede de detection ou de quantification des basophiles et des eosinophiles Abandoned CA2342738A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR98/11456 1998-09-10
FR9811456A FR2783326B1 (fr) 1998-09-10 1998-09-10 Procede de detection ou de quantification des basophiles et des eosinophiles
PCT/FR1999/002145 WO2000016103A1 (fr) 1998-09-10 1999-09-09 Procede de detection ou de quantification des basophiles et des eosinophiles

Publications (1)

Publication Number Publication Date
CA2342738A1 true CA2342738A1 (fr) 2000-03-23

Family

ID=9530419

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002342738A Abandoned CA2342738A1 (fr) 1998-09-10 1999-09-09 Procede de detection ou de quantification des basophiles et des eosinophiles

Country Status (9)

Country Link
US (1) US7101678B1 (https=)
EP (1) EP1112499B1 (https=)
JP (1) JP2002525580A (https=)
AT (1) ATE266870T1 (https=)
AU (1) AU747648B2 (https=)
CA (1) CA2342738A1 (https=)
DE (1) DE69917299T2 (https=)
FR (1) FR2783326B1 (https=)
WO (1) WO2000016103A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4796443B2 (ja) * 2006-06-08 2011-10-19 シスメックス株式会社 試料分析用試薬、試料分析用試薬キット及び試料分析方法
JP4914656B2 (ja) 2006-06-26 2012-04-11 シスメックス株式会社 試料分析用試薬、試料分析用試薬キット及び試料分析方法
JP2009236798A (ja) * 2008-03-28 2009-10-15 Sysmex Corp 好塩基球の分類計数方法
JP5865009B2 (ja) * 2011-10-25 2016-02-17 シスメックス株式会社 活性化好中球の検出方法
RU2698048C2 (ru) * 2017-10-03 2019-08-21 Закрытое Акционерное Общество "Биокад" МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα
WO2020028671A1 (en) * 2018-08-03 2020-02-06 Scripps Health Detection and isolation of myeloid-derived suppressor cell subpopulations
CN116577508A (zh) * 2023-03-16 2023-08-11 江苏博华医药科技有限公司 单克隆抗体Ab614荧光复合物及应用
CN116819076A (zh) * 2023-05-26 2023-09-29 首都医科大学附属北京同仁医院 一种预测或评估抗IL-4Rα单抗在治疗慢性鼻窦炎伴鼻息肉中疗效的生物标志物、应用和方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096704A (en) * 1988-11-03 1992-03-17 Schering Corporation Method of treating eosinophilia
JP2900039B2 (ja) * 1989-09-22 1999-06-02 聖志 高津 マウスインターロイキン５レセプターに対する抗体
TW280833B (https=) * 1990-12-27 1996-07-11 Hoffmann La Roche
DE4120213C2 (de) * 1991-06-19 2000-01-05 Boehringer Ingelheim Int Monoklonale Antikörper gegen das TNF-bindende Protein I (TNF-BP I)
US5627040A (en) * 1991-08-28 1997-05-06 Becton Dickinson And Company Flow cytometric method for autoclustering cells
US5776709A (en) * 1991-08-28 1998-07-07 Becton Dickinson And Company Method for preparation and analysis of leukocytes in whole blood
US5783184A (en) * 1994-12-23 1998-07-21 Smithkline Beecham Corporation Method for treatment and diagnosis of IL-5 mediated disorders
US5693323A (en) * 1994-12-23 1997-12-02 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
US6537764B1 (en) * 1995-01-19 2003-03-25 Children's Medical Center Corporation Method of identifying inhibitors of C—C chemokine receptor 3
ES2233974T3 (es) * 1995-09-11 2005-06-16 Kyowa Hakko Kogyo Co., Ltd. Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana.
US6599914B2 (en) * 2001-04-24 2003-07-29 Schering Corporation Inhibition of cytokine generation

Also Published As

Publication number Publication date
AU5626799A (en) 2000-04-03
EP1112499A1 (fr) 2001-07-04
ATE266870T1 (de) 2004-05-15
FR2783326B1 (fr) 2000-12-01
US7101678B1 (en) 2006-09-05
EP1112499B1 (fr) 2004-05-12
WO2000016103A1 (fr) 2000-03-23
DE69917299D1 (de) 2004-06-17
FR2783326A1 (fr) 2000-03-17
JP2002525580A (ja) 2002-08-13
DE69917299T2 (de) 2005-05-12
AU747648B2 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
JP4450998B2 (ja) フローサイトメトリの全血樹状細胞免疫機能アッセイ
Lingblom et al. Regulatory eosinophils suppress T cells partly through galectin-10
Park et al. Interleukin-13 and interleukin-5 in induced sputum of eosinophilic bronchitis: comparison with asthma
CA2655392A1 (en) Cd127 expression inversely correlates with foxp3 and suppressive function of cd4+ tregs
CN116744962A (zh) Cd25抗体
Shirai et al. Th1/Th2 profile in peripheral blood in atopic cough and atopic asthma
EP1112499B1 (fr) Procede de detection ou de quantification des basophiles et des eosinophiles
EP2379752B1 (fr) Procedes pour determiner la susceptibilite a contracter une infection nosocomiale chez un patient et pour etablir un pronostic d'evolution d'un syndrome septique
Confino-Cohen et al. Low stimulated IL-4 secretion in PBMC from patients with chronic idiopathic urticaria
Silveira-Lemos et al. Eosinophil activation status, cytokines and liver fibrosis in Schistosoma mansoni infected patients
Grenzi et al. Post-transplant soluble CD30 levels are associated with early subclinical rejection in kidney transplantation
Samoszuk IgE in Reed-Sternberg cells of Hodgkin’s disease with eosinophilia
EP0550740B1 (fr) Dosage in vitro de molecules au niveau de leur site de production par des cellules en culture
IL303290A (en) Methods of selectively targeting cd6 high cells and decreasing activity of t eff cells
EP2005181B1 (fr) Standard c4d / c4b pour cytometrie de flux quantitative du rejet humoral de transplantation
US20050003461A1 (en) Method for detecting allergies
WO2024003476A1 (fr) Test fonctionnel pour une determination rapide du statut immunitaire
Désy et al. T follicular helper cells expansion in transplant recipients correlates with graft infiltration and adverse outcomes
Galante et al. Frequency of Vα24+ Vβ11+ NKT cells in peripheral blood of human kidney transplantation recipients
Marshall Novel mechanistic insights into the role of T cells in the pathogenesis of Juvenile Dermatomyositis
Lin et al. Immune characterization of wild-caught Rattus norvegicus suggests diversity of immune activity in biome-normal environments
HK40093014A (zh) 选择性靶向cd6高细胞并降低teff细胞的活性的方法
FR2941239A1 (fr) Procede pour determiner la susceptibilite a contracter une infection nosocomiale chez un patient presentant une reponse systemique inflammatoire associee ou non a une infection.
Seitz B lymphocyte biomarker analysis to risk-stratify clinical outcomes in renal allograft recipients
Rostan et al. Le polynucléaire basophile: nouveautés en physiopathologie et implications diagnostiques

Legal Events

Date Code Title Description
FZDE Discontinued